Markets: 2026-10-19 Close

A sourced recap of the previous completed U.S. trading session. Closing moves are not real-time quotes.

What moved

- **S&P 500 (SPX)**: +0.41%, closed at 7,690.73 - **Nasdaq Composite (COMP)**: +1.11%, closed at 26,430.89 - **Dow Jones Industrial Average (DJIA)**: -0.07%, closed at 51,966.03 - **Russell 2000 (RUT)**: +0.25%, closed at 2,728.3

Sector leaders and laggards

- Leaders: Consumer Discretionary +2.73%; Information Technology +1.19%; Communication Services +0.28% - Laggards: Utilities -1.97%; Real Estate -1.17%; Financials -0.79%

Evidence behind the moves

Silence Therapeutics plc (SLN) +125.58%

Silence announced an agreement to be acquired by Merck KGaA for $20 per American depositary share in cash. The takeover announcement produced the session's largest move among these selected liquid companies.

Sources: October 19 close, change and share volume · Market capitalization · Company-confirmed catalyst

Disc Medicine, Inc. (IRON) +38.86%

Disc reported that its pivotal Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints. A pivotal clinical readout accompanied a nearly 39% closing gain on unusually heavy trading.

Sources: October 19 close, change and share volume · Market capitalization · Company-confirmed catalyst

Cleveland-Cliffs Inc. (CLF) +16.34%

The steelmaker reported third-quarter net income of $165 million, reversing a second-quarter loss, and adjusted EBITDA of $612 million. A substantial earnings-day move in a heavily traded U.S. steel producer.

Sources: October 19 close, change and share volume · Market capitalization · Company-confirmed catalyst

Veradermics, Incorporated (MANE) +12.37%

Veradermics announced positive Phase 3 Study 304 topline results for its investigational oral treatment for male pattern hair loss. A late-stage trial readout moved a multibillion-dollar biotechnology stock.

Sources: October 19 close, change and share volume · Market capitalization · Company-confirmed catalyst

Amazon.com, Inc. (AMZN) +4.98%

Morgan Stanley named Amazon a top pick and raised its price target to $350 from $335, citing potential growth catalysts. A nearly 5% move in a megacap stock helped lift the consumer-discretionary sector.

Sources: October 19 close, change and share volume · Market capitalization · Corroborating report of analyst action

Arcutis Biotherapeutics, Inc. (ARQT) +10.65%

Reporting identified a Guggenheim price-target increase to $44 from $38 while it maintained its buy recommendation. A double-digit gain brought attention to analyst expectations for the company's dermatology treatments.

Sources: October 19 close, change and share volume · Market capitalization · Reported analyst action

Western Digital Corporation (WDC) +6.09%

No specific October 19 company announcement was confirmed as the cause of the gain. The S&P 500's top percentage gainer rebounded after a steep decline in the preceding session.

Sources: October 19 close, change and share volume · Market capitalization · Corroborating dated closing move and S&P 500 ranking

AXT, Inc. (AXTI) +10.34%

No specific October 19 company announcement was confirmed as the cause of the gain. A sharp, highly liquid move in a compound-semiconductor substrate supplier during a technology rebound.

Sources: October 19 close, change and share volume · Market capitalization · Broader-market context, not a confirmed stock-specific catalyst

What remains uncertain

The cited announcements establish events and reported explanations, not the fraction of each price move caused by them. Unconfirmed catalysts remain hypotheses. Closing figures describe this session only.

What to watch next

Check subsequent company filings and results against the claims above, and whether the next sessions sustain or reverse these moves. A follow-up headline alone does not confirm the original explanation.

Stock spotlight

Today’s detailed follow-up focuses on **Silence Therapeutics plc (SLN)**, the strongest verified editorial candidate from this slate.

_MacroShed Markets is informational analysis, not investment advice._